Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy.
Zhang X, Zhang L, Li B, Wang Q, Chen P, Shi R, Zhou X, Niu X, Zhai W, Wu Y, Shen W, Zhou X, Zhao W.
Zhang X, et al. Among authors: shen w.
BMC Biol. 2025 Jan 27;23(1):27. doi: 10.1186/s12915-025-02132-y.
BMC Biol. 2025.
PMID: 39871281